CC
Income statement / Annual
Last year (2024), The Chemours Company's total revenue was $5.78 B,
a decrease of 4.07% from the previous year.
In 2024, The Chemours Company's net income was $86.00 M.
See The Chemours Company,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
Operating Revenue |
$5.78 B |
$6.03 B |
$6.79 B |
$6.35 B |
$4.97 B |
$5.53 B |
$6.64 B |
$6.18 B |
$5.40 B |
$5.72 B |
Cost of Revenue |
$4.63 B
|
$4.72 B
|
$5.18 B
|
$4.96 B
|
$3.90 B
|
$4.46 B
|
$4.67 B
|
$4.43 B
|
$4.29 B
|
$4.76 B
|
Gross Profit |
$1.15 B
|
$1.31 B
|
$1.62 B
|
$1.38 B
|
$1.07 B
|
$1.06 B
|
$1.97 B
|
$1.75 B
|
$1.11 B
|
$955.00 M
|
Gross Profit Ratio |
0.2
|
0.22
|
0.24
|
0.22
|
0.21
|
0.19
|
0.3
|
0.28
|
0.21
|
0.17
|
Research and Development Expenses |
$109.00 M
|
$108.00 M
|
$118.00 M
|
$107.00 M
|
$93.00 M
|
$80.00 M
|
$82.00 M
|
$80.00 M
|
$80.00 M
|
$97.00 M
|
General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$657.00 M
|
$602.00 M
|
$934.00 M
|
$632.00 M
|
Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$585.00 M
|
$1.29 B
|
$710.00 M
|
$592.00 M
|
$527.00 M
|
$548.00 M
|
$657.00 M
|
$602.00 M
|
$934.00 M
|
$632.00 M
|
Other Expenses |
$0.00
|
$0.00
|
$70.00 M
|
$163.00 M
|
$39.00 M
|
-$293.00 M
|
$162.00 M
|
$79.00 M
|
$247.00 M
|
$44.00 M
|
Operating Expenses |
$694.00 M
|
$1.40 B
|
$828.00 M
|
$699.00 M
|
$620.00 M
|
$628.00 M
|
$739.00 M
|
$682.00 M
|
$1.01 B
|
$729.00 M
|
Cost And Expenses |
$5.33 B
|
$6.11 B
|
$6.01 B
|
$5.66 B
|
$4.52 B
|
$5.09 B
|
$5.41 B
|
$5.11 B
|
$5.30 B
|
$5.49 B
|
Interest Income |
$0.00
|
$0.00
|
$163.00 M
|
$185.00 M
|
$210.00 M
|
$208.00 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Interest Expense |
$264.00 M
|
$208.00 M
|
$163.00 M
|
$185.00 M
|
$210.00 M
|
$208.00 M
|
$195.00 M
|
$215.00 M
|
$213.00 M
|
$132.00 M
|
Depreciation & Amortization |
$301.00 M
|
$307.00 M
|
$291.00 M
|
$317.00 M
|
$320.00 M
|
$311.00 M
|
$284.00 M
|
$273.00 M
|
$284.00 M
|
$267.00 M
|
EBITDA |
$692.00 M |
$197.00 M |
$1.20 B |
$1.21 B |
$767.00 M |
$482.00 M |
$1.54 B |
$1.35 B |
$715.00 M |
$211.00 M |
EBITDA Ratio |
0.12
|
0.03
|
0.18
|
0.19
|
0.17
|
0.09
|
0.26
|
0.24
|
0.12
|
0.1
|
Operating Income Ratio |
0.08
|
-0.02
|
0.13
|
0.14
|
0.1
|
0.03
|
0.19
|
0.17
|
0.02
|
0.04
|
Total Other Income/Expenses Net |
-$330.00 M
|
-$226.00 M
|
-$45.00 M
|
-$6.00 M
|
-$268.00 M
|
-$536.00 M
|
-$77.00 M
|
-$160.00 M
|
-$107.00 M
|
-$414.00 M
|
Income Before Tax |
$127.00 M
|
-$318.00 M
|
$741.00 M
|
$676.00 M
|
$179.00 M
|
-$124.00 M
|
$1.16 B
|
$912.00 M
|
-$11.00 M
|
-$188.00 M
|
Income Before Tax Ratio |
0.02
|
-0.05
|
0.11
|
0.11
|
0.04
|
-0.02
|
0.17
|
0.15
|
-0
|
-0.03
|
Income Tax Expense |
$41.00 M
|
-$81.00 M
|
$163.00 M
|
$68.00 M
|
-$40.00 M
|
-$72.00 M
|
$159.00 M
|
$165.00 M
|
-$18.00 M
|
-$98.00 M
|
Net Income |
$86.00 M
|
-$238.00 M
|
$578.00 M
|
$608.00 M
|
$219.00 M
|
-$52.00 M
|
$995.00 M
|
$746.00 M
|
$7.00 M
|
-$90.00 M
|
Net Income Ratio |
0.01
|
-0.04
|
0.09
|
0.1
|
0.04
|
-0.01
|
0.15
|
0.12
|
0
|
-0.02
|
EPS |
0.58 |
-1.6 |
3.72 |
3.69 |
1.33 |
-0.32 |
5.62 |
4.04 |
0.04 |
-0.5 |
EPS Diluted |
0.57 |
-1.6 |
3.65 |
3.6 |
1.32 |
-0.32 |
5.45 |
3.91 |
0.04 |
-0.5 |
Weighted Average Shares Out |
$149.49 M
|
$148.91 M
|
$155.36 M
|
$164.94 M
|
$164.68 M
|
$164.82 M
|
$176.97 M
|
$184.84 M
|
$181.62 M
|
$180.00 M
|
Weighted Average Shares Out Diluted |
$150.01 M
|
$148.91 M
|
$158.30 M
|
$168.70 M
|
$166.35 M
|
$164.82 M
|
$182.57 M
|
$190.98 M
|
$183.42 M
|
$180.99 M
|
Link |
|
|
|
|
|
|
|
|
|
|